Nonactin hinders intracellular glycosylation in virus-infected baby hamster kidney cells

Molecular Medicine Reports

Volumn 3, Issue 1, 2010, Pages 115-119

  Lee, Jin Man ^a   Kim, Jong Guk ^b   Kim, Tae Ho ^c   Lee, Do Seung ^d   Kim, Jae Hoon ^d   Cho, Somi K ^d   Riu, Key Zung ^d   Lee, Dong Sun ^d   Lee, Sang Han ^b  

^a Hoseo University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Jeju National University   (South Korea)

Author keywords

Anti viral; Inhibitor; Intracellular glycosylation; Nonactin; Trafficking

Indexed keywords

ANTIVIRUS AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; HN PROTEIN; NONACTIN; SUPEROXIDE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CELL STRAIN BHK; CELL SURFACE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GLYCOPROTEIN SYNTHESIS; GLYCOSYLATION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; SYNCYTIUM; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

CRICETINAE; NEWCASTLE DISEASE VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 76149143997     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000227     Document Type: Article

References (25)

1. Wattenberg BG: Glycolipid and glycoprotein transport through the Golgi complex are similar biochemically and kinetically. Reconstitution of glycolipid transport in a cell free system. J Cell Biol 111: 421-428, 1990.
2. Bos CR, Shank SL and Snider MD: Role of clathrin-coated vesicles in glycoprotein transport from the cell surface to the Golgi complex. J Biol Chem 270: 665-671, 1995.
3. Muñiz M and Riezman H: Intracellular transport of GPI-anchored proteins. EMBO J 19: 10-15, 2000.
4. Hunziker W and Geuze HJ: Intracellular trafficking of lysosomal membrane proteins. Bioessays 18: 379-389, 1996.
5. Spearman P: Cellular cofactors involved in HIV assembly and budding. Curr Opin HIV AIDS 1: 200-207, 2006.
6. Olkkonen VM and Ikonen E: When intracellular logistics fails - genetic defects in membrane trafficking. J Cell Sci 119: 5031-5045, 2006.
7. Happe S and Weidman P: Cell-free transport to distinct Golgi cisternae is compartment specific and ARF independent. J Cell Biol 140: 511-523, 1998.
8. Mironov AA, Colanzi A, Polishchuk RS, Beznoussenko GV, Mironov AA Jr, Fusella A, Di Tullio G, Silletta MG, Corda D, De Matteis MA and Luini A: Dicumarol, an inhibitor of ADP-ribosylation of CtBP3/BARS, fragments Golgi non-compact tubular zones and inhibits intra-golgi transport. Eur J Cell Biol 83: 263-279, 2004.
9. Lad VJ and Gupta AK: Inhibition of Japanese encephalitis virus maturation and transport in PS cells to cell surface by brefeldin A. Acta Virol 46: 187-190, 2002.
10. Thomas G: Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3: 753-766, 2002.
11. Sheetz MP, Pfister KK, Bulinski JC and Cotman CW: Mechanisms of trafficking in axons and dendrites: implications for development and neurodegeneration. Prog Neurobiol 55: 577-594, 1998.
12. Lee JM, Lee DS, Lee SH, Hong SD and Kim JG: Antibacterial activities of nanactin from Streptomyces viridochromogenes JM-4151. J Life Sci 10: 45-47, 2000.
13. Barry AL, Creitz L and Packer PP: Feasibility study of disk diffusion susceptibility tests with Mueller-Hinton broth solidified with Gelrite, an agar substitute. J Clin Microbiol 21: 409-414, 1985.
14. Smaill F: Antibiotic susceptibility and resistance testing: an overview. Can J Gastroenterol 14: 871-875, 2000.
15. Baker JR, Zyzak DV, Thorpe SR and Baynes JW: Mechanism of fructosamine assay: evidence against role of superoxide as intermediate in nitroblue tetrazolium reduction. Clin Chem 39: 2460-2465, 1993.
16. Lee DS, Lee SH, Noh JG and Hong SD: Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza, Bunge. Biosci Biotechnol Biochem 63: 2236-2239, 1999.
17. Muroi M, Takasu A, Yamasaki M and Takatsuki A: Folimycin (concanamycin A), an inhibitor of V-type H(+)-ATPase, blocks cell-surface expression of virus-envelope glycoproteins. Biochem Biophys Res Commun 193: 999-1005, 1993.
18. Muroi M, Shiragami N and Takatsuki A: Destruxin, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase. Biochem Biophys Res Commun 205: 1358-1365, 1994.
19. Kisch AL, Kelley RO and Eberle BJ: Differential enhancement of R-type virus particles in polyoma-transformed BHK-21 cells by dimethyl sulfoxide. J Natl Cancer Inst 49: 911-914, 1972.
20. Osburne MS, Maiese WM and Greenstein M: An assay for the detection of bacterial DNA gyrase inhibitors. J Antibiot 46: 1764-1766, 1993.
21. Nakamura M, Kono Y and Takatsuki A: Mepanipyrim, a novel inhibitor of pharmacologically induced Golgi dispersion. Biosci Biotechnol Biochem 67: 139-150, 2003.
22. Zizi M, Fisher RS and Grillo FG: Formation of cation channels in planar lipid bilayers by brefeldin A. J Biol Chem 266: 18443-18445, 1991.
23. Hiebsch RR and Wattenberg BW: Vesicle fusion in protein transport through the Golgi in vitro does not involve long-lived prefusion intermediates. A reassessment of the kinetics of transport as measured by glycosylation. Biochemistry 31: 6111-6118, 1992.
24. Muroi M, Suehara K, Wakusawa H, Suzuki K, Sato T, Nishimura T, Otake N and Takatsuki A: Novel blockade of cell surface expression of virus glycoproteins by leucinostatin A. J Antibiot 49: 1119-1126, 1996.
25. Quinn TC: HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS 22 (Suppl 3): 7-12, 2008.